Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.7B
Avg Funding
$66.2M
Global Reach
7
countries

Top Cities for Therapeutics

Wakefield
Sydney
Redwood City
Halifax
San Francisco
Los Angeles

Recently Funded Companies

Export
Wakefield, United States

Biotherapeutics Analytical Instrumentation for AI, R&D and Manufacturing [ HT multi-attribute multi-variate (MAM) and label free analysis].

$1.8M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Sydney, Australia

Understanding Zoe is a neuroaffirming application that turns every report and observation into an actionable step for a better connect.

$499K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

$350.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Halifax, Canada

Appili Therapeutics is an anti-infective pharmaceutical development company.

$532K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

$185.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

$400K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.

$300K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.

$3.6M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Milano, Italy

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

$141.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Wilmington, United States

‘Off-the-Shelf’ Curative Cell Therapies

$12.5M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Miyagi, Japan

Airato is a radiotherapy provider that uses artificial intelligence to develop radiation therapy and other medical devices.

$1.1M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Norwalk, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

$4.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

$3.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Rarity is a biotechnology company that offers genetic treatments for immune diseases.

$4.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

$47.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Newton, United States

MelliCell develops technology that studies and uses fat cells to find new treatments for chronic diseases.

Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

$155.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

$250.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Saint Paul, United States

Agitated Solutions is a healthcare company that delivers microbubble treatment for patients with hypoxemic respiratory failure.

$3.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boulder, United States

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

$17.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

$250.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

$25.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.

$11.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Jose, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

$60.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

$125.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Showing 476 to 500 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$66.2M
Total Funding Tracked
$1.7B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
4 companies$330.9M
2.San Francisco
3 companies$460.0M
3.Los Angeles
2 companies$5.0M
4.South San Francisco
2 companies$250.3M
5.Wakefield
1 companies$1.8M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked